430P Assessment of the prognostic value of circulating tumor cells (CTCs) and peripheral blood mononuclear cells (PBMCs) in extensive-stage small cell lung cancer (ES-SCLC)
Conclusions: Lurbinectedin was associated with clinically meaningful effectiveness and predictable/manageable safety for previously treated ES-SCLC in a RW population, including poor-prognosis subgroups.
Authors
- S. Angelaki
- Sofia Chatziavraam
- A. Boumpouli
- D. Mavroudis
- E. Vorrias
- M.A. Papadaki
- C. Zioudas
Institutions
- University of Crete (GR)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.esmoop.2026.106744
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00